Juvenile idiopathic arthritis (JIA) and pediatric joint disorders
Rebecca Trachtman, MD, MS
Icahn School of Medicine at Mount Sinai
New York, NY, United States
Disclosure(s): No financial relationships to disclose
This session is targeted at adult rheumatology providers that see pediatric patients. Juvenile arthritis has changed to many names over the last several decades, including juvenile rheumatoid arthritis, juvenile chronic arthritis and juvenile idiopathic arthritis (JIA).
Similarly, treatment landscape for JIA has changed drastically over the last several decades moving toward early achievement of remission with disease modifying therapy. Currently, the International League of Associations for Rheumatology (ILAR) classifies JIA into seven discrete categories. This session will discuss an overview of common clinical presentations of JIA and systemic JIA (SJIA) followed by an evidence-based discussion around the evolution of JIA treatment and outcomes over the last several decades.
Speaker: Michael Ombrello, MD – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
Speaker: Angelo Ravelli, MD – IRCCS Istituto Giannina Gaslini, Genoa, Italy
